Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04410445
Title Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence (PIVOT-12)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Nektar Therapeutics

skin melanoma



Nivolumab + NKTR-214

Age Groups: senior | adult | child
Covered Countries USA | ITA | FRA | ESP | DEU | AUT

No variant requirements are available.